JP2009526524A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526524A5
JP2009526524A5 JP2008554415A JP2008554415A JP2009526524A5 JP 2009526524 A5 JP2009526524 A5 JP 2009526524A5 JP 2008554415 A JP2008554415 A JP 2008554415A JP 2008554415 A JP2008554415 A JP 2008554415A JP 2009526524 A5 JP2009526524 A5 JP 2009526524A5
Authority
JP
Japan
Prior art keywords
gene
protein
subject
cfh
polymorphism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008554415A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526524A (ja
JP5290772B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/003696 external-priority patent/WO2007095185A2/en
Publication of JP2009526524A publication Critical patent/JP2009526524A/ja
Publication of JP2009526524A5 publication Critical patent/JP2009526524A5/ja
Application granted granted Critical
Publication of JP5290772B2 publication Critical patent/JP5290772B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008554415A 2006-02-13 2007-02-13 補体調節遺伝子における変異体が加齢性黄斑変性症を予測する Expired - Fee Related JP5290772B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77298906P 2006-02-13 2006-02-13
US60/772,989 2006-02-13
PCT/US2007/003696 WO2007095185A2 (en) 2006-02-13 2007-02-13 Variants in complement regulatory genes predict age-related macular degeneration

Publications (3)

Publication Number Publication Date
JP2009526524A JP2009526524A (ja) 2009-07-23
JP2009526524A5 true JP2009526524A5 (enExample) 2011-03-24
JP5290772B2 JP5290772B2 (ja) 2013-09-18

Family

ID=38372062

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008554415A Expired - Fee Related JP5290772B2 (ja) 2006-02-13 2007-02-13 補体調節遺伝子における変異体が加齢性黄斑変性症を予測する

Country Status (8)

Country Link
EP (1) EP1989319A4 (enExample)
JP (1) JP5290772B2 (enExample)
CN (1) CN101421409A (enExample)
AU (1) AU2007215218B2 (enExample)
CA (1) CA2638916A1 (enExample)
IL (1) IL193396A (enExample)
NZ (1) NZ570431A (enExample)
WO (1) WO2007095185A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012683B2 (en) 2006-02-13 2011-09-06 University Of Iowa Research Foundation Variants in complement regulatory genes predict age-related macular degeneration
WO2010127176A2 (en) * 2009-04-29 2010-11-04 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing detecting age-related macular degeneration
EP2963128A1 (en) 2009-07-10 2016-01-06 The Regents of the University of Michigan Compositions and methods for diagnosing and treating macular degeneration
US20110104154A1 (en) * 2009-10-30 2011-05-05 Alcon Research, Ltd. Single nucleotide polymorphisms and genes associated with age-related macular degeneration
US9056874B2 (en) 2012-05-04 2015-06-16 Novartis Ag Complement pathway modulators and uses thereof
CN102707068B (zh) * 2012-05-31 2015-03-18 北京大学 补体h因子用作甲基苯丙胺成瘾患者的基因表达产物中的应用
JP6387391B2 (ja) 2013-03-14 2018-09-05 ノバルティス アーゲー 眼科疾患の処置に有用な補体因子B阻害剤としての2−(1H−インドール−4−イルメチル)−3H−イミダゾ[4,5−b]ピリジン−6−カルボニトリル誘導体
EP3089963A1 (en) 2013-10-30 2016-11-09 Novartis AG 2-benzyl-benzimidazole complement factor b inhibitors and uses thereof
EP3102701A1 (en) * 2014-02-07 2016-12-14 Novartis AG Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy
WO2016100745A2 (en) * 2014-12-19 2016-06-23 Children's Hospital Medical Center Methods and compositions related to transplant-associated thrombotic microangiopathy
CN109082460B (zh) * 2018-09-27 2021-07-13 领航基因科技(杭州)有限公司 应用于snp分型的非竞争性探针设计方法、检测方法及应用
KR102414152B1 (ko) * 2020-08-20 2022-06-29 (주)지놈오피니언 연령 관련 황반변성 진단용 바이오마커 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU575586B2 (en) 1983-09-02 1988-08-04 Syngene, Inc. Oligonucleotide synthesis employing primer with oxidzable substituents in system
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5554501A (en) 1992-10-29 1996-09-10 Beckman Instruments, Inc. Biopolymer synthesis using surface activated biaxially oriented polypropylene
DE69503126T2 (de) 1994-05-05 1998-11-12 Beckman Instruments Inc Repetitive oligonukleotide matrix
US5985567A (en) 1997-08-15 1999-11-16 Beckman Coulter, Inc. Hybridization detection by pretreating bound single-stranded probes
US6013789A (en) 1998-02-20 2000-01-11 Beckman Coulter, Inc. Covalent attachment of biomolecules to derivatized polypropylene supports
WO2006062716A2 (en) * 2004-11-18 2006-06-15 Yale University Methods and compositions for treating ocular disorders

Similar Documents

Publication Publication Date Title
JP2009526524A5 (enExample)
JP2014533949A5 (enExample)
US20110189685A1 (en) Methods of using jak3 genetic variants to diagnose and predict crohn's disease
JP2011528903A5 (enExample)
US20120073585A1 (en) Methods of predicting complication and surgery in crohn's disease
US20100075335A1 (en) Colorimetric method and kit for the detection of specific nucleic acid sequences using metal nanoparticles functionalized with modified oligonucleotides
Harakalova et al. Multiplexed array-based and in-solution genomic enrichment for flexible and cost-effective targeted next-generation sequencing
KR102303638B1 (ko) 알츠하이머성 치매가 발병될 가능성 평가방법
ES2616110T3 (es) Método de una etapa de elución de ADN a partir de muestras de sangre
JP2010528590A5 (enExample)
JP2012501452A5 (enExample)
WO2014181107A1 (en) Genetic method of aiding the diagnosis and treatment of familial hypercholersterolaemia
JP2013544536A5 (enExample)
CN108012546A (zh) Snp rs12603226作为nafld的预测性标记物
JP2011517937A5 (enExample)
WO2011017120A1 (en) Use of ccr9, ccl25, batf and il17/il23 pathway variants to diagnose and treat inflammatory bowel disease
Xu et al. Family association study between INSR gene polymorphisms and PCOS in Han Chinese
WO2011116111A1 (en) Methods of using prdm1 genetic variants to prognose, diagnose and treat inflammatory bowel disease
US10939868B2 (en) Method of predicting rapid progression of fibrosis and therapy and reagents therefor
JP6544737B2 (ja) バイオマーカーによるうつ病の検査方法及び検査キット
Kiliś-Pstrusińska et al. The rs1800471 polymorphism of TGFB1 gene, serum TGF-beta1 level and chronic kidney disease progression
Boissinot et al. Real-time monitoring of bead-based DNA hybridization in a microfluidic system: study of amplicon hybridization behavior on solid supports
TWI661050B (zh) 評估子宮頸癌風險之方法
JP2010246527A (ja) 化学物質が生体に与える影響の予測方法、これに用いるプローブセット及び検出又は定量用キット
JP7540730B2 (ja) 関節リウマチを検査する方法